Replies to post #207046 on Biotech Values

[DewDiligence]

GILD prevails against MRK in CAFC Sovaldi ruling:

https://www.reuters.com/article/gilead-knocks-out-merck-patent-on-hepati-idUSL1N1JI23E

An appeals court handed biopharmaceutical company Gilead Sciences Inc a victory on Tuesday in its litigation with Merck & Co Inc over the blockbuster hepatitis C drug Sovaldi.

Upholding a determination by the U.S. Patent & Trademark Office, the U.S. Court of Appeals for the Federal Circuit ruled that a patent owned by Merck subsidiary Idenix Pharmaceuticals Inc on a method of treating hepatitis C was invalid.